Mepolizumab, sold under the brand name Nucala, is a humanized monoclonal antibody used for the treatment of severe eosinophilic asthma, eosinophilic granulomatosis with polyangiitis, and hypereosinophilic syndrome. The most common side effects include headache, injection site reactions, and back pain.
Mepolizumab, sold under the brand name Nucala, is a humanized monoclonal antibody used for the treatment of severe eosinophilic asthma, eosinophilic granulomatosis with polyangiitis, and hypereosinophilic syndrome. The most common side effects include headache, injection site reactions, and back pain.
Source: Wikipedia "Mepolizumab" · CC BY-SA 4.0
Share this article: X · Bluesky